Emergence of Biotechnology Platforms During COVID-19
Abstract
The COVID-19 pandemic has accelerated the development and manufacturing of vaccines at an unprecedented rate. This has been enabled by the emergence of biotechnology platforms such as mRNA and Viral Vectors.
This seminar will outline the engineering aspects of such platforms, the modern biology behind their evolution, and how they are affecting smart product development and manufacturing in this important field.
Speaker Bio
Dr. Vijay Srinivasan is a Senior Advisor in the Engineering Laboratory at the National Institute of Standards and Technology, Gaithersburg, Maryland, U.S. He joined NIST in 2009, after 26 years at IBM Research during which he was also an Adjunct Professor at Columbia University, New York. Dr. Srinivasan has published widely and is a Fellow of AAAS (American Association for the Advancement of Science) and ASME (The American Society of Mechanical Engineers).